T Cells

A freshly discovered human cell type opens new research paths for understanding celiac disease, multiple sclerosis, and lupus. 

With videos of dramatic cancer cell deaths and unflagging T cell attacks, Alex Ritter studies how immune cells and tumors battle with microscopic precision.

The immune system comprises a treasure trove of cell types with the potential to destroy cancer cells.

Small molecule drugs that trigger the death of cells storing latent viruses are a promising approach for treating HIV. Researchers identified a potent compound in a marine sponge — a more likely source than it may seem.  

T cells that react to a Parkinson’s disease-linked protein have an early, unique, and detectable gene signature.

In children, T cells effectively combat acute infections such as COVID-19, but a new study in mice suggests that the T cell response is detrimental when fighting pediatric tumors.

LIVE June 22nd, 2021 at 2:30 PM ET

This webinar will explore recent discoveries about the way the immune system responds to SARS-CoV-2 infection.

Researchers originally believed that macrophages existed in only pro- and anti-inflammatory varieties. Over time, it became clear that many different macrophage types and subtypes exist in physiological and pathological situations. Macrophage heterogeneity brings incredible diversity to the purpose and function of these remarkable cells, but also complicates understanding how macrophages affect health and disease.

LIVE May 20th, 2021 at 2:30 PM ET
In this webinar, Berkeley Lights scientists present a new platform for antibody discovery and cell line development that accelerates the identification and production of leading therapeutic molecules.

Immunotherapy is typically thought of in the context of cancer treatment, but many of the same therapies used to activate the immune system to treat cancer may also combat infectious diseases.